CHMA
Price:
$3.76
Market Cap:
$0
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2015-07-16
Stock Exchange
NASDAQ
Ticker
CHMA
According to Chiasma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -15462000.00. This represents a change of -107.77% compared to the average of 199.12M of the last 4 quarters.
The mean historical Enterprise Value of Chiasma, Inc. over the last ten years is 148.77M. The current -15462000.00 Enterprise Value has changed -1139.33% with respect to the historical average. Over the past ten years (40 quarters), CHMA's Enterprise Value was at its highest in in the December 2015 quarter at 438.77M. The Enterprise Value was at its lowest in in the March 2014 quarter at 0.
Average
148.77M
Median
144.03M
Minimum
69.01M
Maximum
266.90M
Discovering the peaks and valleys of Chiasma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.99%
Maximum Annual Enterprise Value = 266.90M
Minimum Annual Increase = -62.22%
Minimum Annual Enterprise Value = 69.01M
Year | Enterprise Value | Change |
---|---|---|
2020 | 211.76M | 46.73% |
2019 | 144.32M | 56.99% |
2018 | 91.93M | 15.17% |
2017 | 79.82M | 15.66% |
2016 | 69.01M | -62.22% |
2015 | 182.68M | 27.10% |
2014 | 143.73M | -46.15% |
The current Enterprise Value of Chiasma, Inc. (CHMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
149.34M
5-year avg
119.37M
10-year avg
148.77M
Chiasma, Inc.’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chiasma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chiasma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Chiasma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Chiasma, Inc. (CHMA)?
What is the 3-year average Enterprise Value for Chiasma, Inc. (CHMA)?
What is the 5-year average Enterprise Value for Chiasma, Inc. (CHMA)?
How does the current Enterprise Value for Chiasma, Inc. (CHMA) compare to its historical average?